GailCawkwellMD

Physician

Dr. Cawkwell is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
Columbia
3959 Broadway Bhn 106
New York, NY 10032
Phone+1 212-305-9304

PubMed

52 citations
Obeticholic Acid Impact on Quality of Life in Patients With Nonalcoholic Steatohepatitis: REGENERATE 18-Month Interim Analysis.
Zobair M. Younossi, Maria Stepanova, Fatema Nader, Rohit Loomba, Quentin M. Anstee
Clinical Gastroenterology and Hepatology. 2021-07-15
18 citations
The hepatic safety and tolerability of the cyclooxygenase-2 selective NSAID celecoxib: pooled analysis of 41 randomized controlled trials.
Paresh Soni, Briton Shell, Gail Cawkwell, Chunming Li, Hong Ma
Current Medical Research and Opinion. 2009-07-20
36 citations
The role of aggressive corticosteroid therapy in patients with juvenile dermatomyositis: a propensity score analysis.
Roopa Seshadri, Brian M. Feldman, Norman T. Ilowite, Gail Cawkwell, Lauren M. Pachman
Arthritis and Rheumatism. 2008-07-15

Intercept Appoints M. Michelle Berrey, M.D., M.P.H., as President of Research & Development and Chief Medical OfficerJune 9th, 2021
Intercept Announces Updated Ocaliva® (Obeticholic Acid) U.S. Prescribing InformationMay 26th, 2021
Chutes & Ladders—Moderna CMO Hits Exit Amid COVID-19 Vaccine RolloutFebruary 26th, 2021
Join now to see all